Rhinorrhea and olfaction in Parkinson disease.
Landis
Basile N
BN
Burkhard
Pierre R
PR
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000009:adverse effects; D016022:Case-Control Studies; D015897:Comorbidity; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa / Q000294:innervation / Q000378:metabolism / Q000503:physiopathology; D000857:Olfaction Disorders / Q000453:epidemiology* / Q000503:physiopathology; D017777:Parasympathetic Fibers, Postganglionic / Q000503:physiopathology; D010300:Parkinson Disease / Q000453:epidemiology* / Q000503:physiopathology; D015995:Prevalence; D012220:Rhinitis / Q000453:epidemiology* / Q000503:physiopathology; D017678:Sex Distribution; D017779:Sympathetic Fibers, Postganglionic / Q000503:physiopathology
D000978:Antiparkinson Agents; D007980:Levodopa